InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Modular Medical, Inc.

MODD Clue Score30
United States Fiscal year ends March CIK 0001074871
$2.72 +2.26% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.72 +20.89% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue0.0Operating income−0.1Net income−0.1Fiscal year 2018Revenue0.0Operating income−0.7Net income−0.7Fiscal year 2019Operating income−2.6Net income−2.5Fiscal year 2020Operating income−5.3Net income−5.3Fiscal year 2021Operating income−7.3Net income−7.4Fiscal year 2022Operating income−14.9Net income−18.6EPS, diluted−2.74Fiscal year 2023Operating income−13.9Net income−13.9EPS, diluted−1.15Fiscal year 2024Operating income−17.5Net income−17.5EPS, diluted−0.78Fiscal year 2025Operating income−19.0Net income−18.8EPS, diluted−15.26Fiscal year 2026Operating income−27.6Net income−28.2EPS, diluted−12.36
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 0.0 0.0 n/a n/a n/a n/a n/a n/a n/a n/a
Growth
Operating income −0.1 −0.7 −2.6 −5.3 −7.3 −14.9 −13.9 −17.5 −19.0 −27.6
Net income −0.1 −0.7 −2.5 −5.3 −7.4 −18.6 −13.9 −17.5 −18.8 −28.2
Growth
EPS, diluted n/a n/a n/a n/a n/a −2.74 −1.15 −0.78 −15.26 −12.36

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−0.1Buybacks−0.0Fiscal year 2018Operating cash flow−0.8Capital expenditure−0.0Free cash flow−0.8Buybacks0.0Fiscal year 2019Operating cash flow−1.8Capital expenditure−0.1Free cash flow−1.9Fiscal year 2020Operating cash flow−4.1Capital expenditure−0.3Free cash flow−4.4Fiscal year 2021Operating cash flow−5.9Capital expenditure−0.1Free cash flow−6.0Fiscal year 2022Operating cash flow−10.3Capital expenditure−0.1Free cash flow−10.3Fiscal year 2023Operating cash flow−11.0Capital expenditure−1.6Free cash flow−12.6Fiscal year 2024Operating cash flow−14.0Capital expenditure−1.7Free cash flow−15.7Fiscal year 2025Operating cash flow−15.7Capital expenditure−2.5Free cash flow−18.2Fiscal year 2026Operating cash flow−23.8Capital expenditure−3.9Free cash flow−27.7
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −0.1 −0.8 −1.8 −4.1 −5.9 −10.3 −11.0 −14.0 −15.7 −23.8
Capital expenditure n/a −0.0 −0.1 −0.3 −0.1 −0.1 −1.6 −1.7 −2.5 −3.9
Free cash flow n/a −0.8 −1.9 −4.4 −6.0 −10.3 −12.6 −15.7 −18.2 −27.7
Growth
Buybacks −0.0 0.0 n/a n/a n/a n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash1.4Shareholders’ equity1.3Fiscal year 2018Cash4.3Shareholders’ equity4.3Fiscal year 2019Cash6.6Shareholders’ equity6.5Fiscal year 2020Cash3.1Shareholders’ equity2.9Fiscal year 2021Cash1.5Shareholders’ equity−1.3Fiscal year 2022Cash9.1Shareholders’ equity8.8Fiscal year 2023Cash3.8Shareholders’ equity5.1Fiscal year 2024Cash9.2Shareholders’ equity11.5Fiscal year 2025Cash13.1Shareholders’ equity17.1Fiscal year 2026Cash6.9Shareholders’ equity13.0
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 1.4 4.3 6.6 3.1 1.5 9.1 3.8 9.2 13.1 6.9
Shareholders’ equity 1.3 4.3 6.5 2.9 −1.3 8.8 5.1 11.5 17.1 13.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending March, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Mar 2017 FY2017† 30 Jun 2017 FY2018† 31 Mar 2018 FY2019 31 Mar 2019 FY2020 31 Mar 2020 FY2021 31 Mar 2021 FY2022† 31 Mar 2022 FY2023† 31 Mar 2023 FY2024† 31 Mar 2024 FY2025† 31 Mar 2025 FY2026† 31 Mar 2026
Revenue and profit
0.0 0.0 0.0 n/a n/a n/a n/a n/a n/a n/a n/a
Growth
0.0 n/a 0.3 1.9 3.0 4.1 7.7 9.1 12.9 14.7 20.0
0.0 0.1 0.1 0.7 2.3 3.3 7.2 4.8 4.6 4.4 7.6
−0.0 −0.1 −0.7 −2.6 −5.3 −7.3 −14.9 −13.9 −17.5 −19.0 −27.6
Growth
−0.0 −0.1 −0.7 −2.5 −5.3 −7.4 −18.6 −13.9 −17.5 −18.8 −28.2
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
−0.0 −0.1 −0.7 −2.5 −5.3 −7.4 −18.6 −13.9 −17.5 −18.8 −28.2
Growth
Per share
n/a n/a n/a n/a n/a n/a −2.74 −1.15 −0.78 −15.26 −12.36
n/a n/a n/a n/a n/a n/a −2.74 −1.15 −0.78 −15.26 −12.36
Growth
9.7 1.7 13.3 16.6 n/a n/a 6.8 12.1 22.4 1.2 2.3
9.7 1.7 13.3 16.6 n/a n/a 6.8 12.1 22.4 1.2 2.3
Growth −83.0% +707.5% +24.4% +77.8% +84.9% −94.5% +85.3%

† The diluted share count jumps at 2017 and 2018 and 2022 and 2023 and 2024 and 2025 and 2026, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 11 of 11 years on file.